• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Palmitoylation of pulmonary surfactant protein SP-C is critical for its functional cooperation with SP-B to sustain compression/expansion dynamics in cholesterol-containing surfactant films.棕榈酰化肺表面活性蛋白 SP-C 对于其与 SP-B 的功能合作至关重要,以维持含有胆固醇的表面活性剂膜的压缩/扩张动力学。
Biophys J. 2010 Nov 17;99(10):3234-43. doi: 10.1016/j.bpj.2010.08.070.
2
Pulmonary surfactant protein SP-C counteracts the deleterious effects of cholesterol on the activity of surfactant films under physiologically relevant compression-expansion dynamics.肺表面活性物质蛋白 SP-C 可对抗胆固醇在生理相关压缩-扩张动力学下对表面活性剂膜活性的有害影响。
Biophys J. 2009 Nov 18;97(10):2736-45. doi: 10.1016/j.bpj.2009.08.045.
3
Combined and independent action of proteins SP-B and SP-C in the surface behavior and mechanical stability of pulmonary surfactant films.SP-B 和 SP-C 蛋白在肺表面活性物质膜表面行为和机械稳定性中的联合和独立作用。
Biophys J. 2010 Nov 17;99(10):3290-9. doi: 10.1016/j.bpj.2010.09.039.
4
Segregated ordered lipid phases and protein-promoted membrane cohesivity are required for pulmonary surfactant films to stabilize and protect the respiratory surface.肺表面活性剂薄膜需要分隔有序的脂质相和蛋白促进的膜内聚性来稳定和保护呼吸表面。
Faraday Discuss. 2013;161:535-48; discussion 563-89. doi: 10.1039/c2fd20096a.
5
Palmitoylation as a key factor to modulate SP-C-lipid interactions in lung surfactant membrane multilayers.棕榈酰化作为调节肺表面活性物质膜多层结构中SP-C-脂质相互作用的关键因素。
Biochim Biophys Acta. 2015 Jan;1848(1 Pt A):184-91. doi: 10.1016/j.bbamem.2014.10.009. Epub 2014 Oct 12.
6
Effects of cholesterol on surface activity and surface topography of spread surfactant films.胆固醇对铺展表面活性剂膜的表面活性和表面形貌的影响。
Biochemistry. 2002 Dec 17;41(50):15007-16. doi: 10.1021/bi0256532.
7
Role of the palmitoylation of surfactant-associated protein C in surfactant film formation and stability.表面活性物质相关蛋白C的棕榈酰化在表面活性物质膜形成及稳定性中的作用
Am J Physiol. 1996 Oct;271(4 Pt 1):L572-80. doi: 10.1152/ajplung.1996.271.4.L572.
8
A Combination of Short and Simple Surfactant Protein B and C Analogues as a New Synthetic Surfactant: In Vitro and Animal Experiments.短而简单的表面活性蛋白B和C类似物组合作为新型合成表面活性剂:体外和动物实验
Yonsei Med J. 2017 Jul;58(4):823-828. doi: 10.3349/ymj.2017.58.4.823.
9
Palmitoylation of a pulmonary surfactant protein C analogue affects the surface associated lipid reservoir and film stability.肺表面活性物质蛋白C类似物的棕榈酰化作用会影响表面相关脂质储备和膜稳定性。
Biochim Biophys Acta. 2000 Jun 1;1466(1-2):169-78. doi: 10.1016/s0005-2736(00)00198-x.
10
Surface activity in vitro: role of surfactant proteins.体外表面活性:表面活性蛋白的作用
Comp Biochem Physiol A Mol Integr Physiol. 2001 May;129(1):209-20. doi: 10.1016/s1095-6433(01)00317-8.

引用本文的文献

1
Exploring protein-protein interactions and oligomerization state of pulmonary surfactant protein C (SP-C) through FRET and fluorescence self-quenching.通过荧光共振能量转移(FRET)和荧光自猝灭技术研究肺表面活性蛋白 C(SP-C)的蛋白-蛋白相互作用和寡聚状态。
Protein Sci. 2024 Jan;33(1):e4835. doi: 10.1002/pro.4835.
2
The concentration-dependent effect of hydrocortisone on the structure of model lung surfactant monolayer by using an approach.采用一种方法研究氢化可的松对模型肺表面活性剂单层结构的浓度依赖性效应。
RSC Adv. 2022 Nov 22;12(51):33313-33328. doi: 10.1039/d2ra05268g. eCollection 2022 Nov 15.
3
Increased Alveolar Heparan Sulphate and Reduced Pulmonary Surfactant Amount and Function in the Mucopolysaccharidosis IIIA Mouse.黏多糖贮积症 IIIA 型小鼠肺泡肝素硫酸含量增加和肺表面活性物质含量及功能降低。
Cells. 2021 Apr 8;10(4):849. doi: 10.3390/cells10040849.
4
GM130 regulates pulmonary surfactant protein secretion in alveolar type II cells.GM130 调节肺泡 II 型细胞中肺表面活性蛋白的分泌。
Sci China Life Sci. 2022 Jan;65(1):193-205. doi: 10.1007/s11427-020-1875-x. Epub 2021 Mar 16.
5
Lipid-Protein and Protein-Protein Interactions in the Pulmonary Surfactant System and Their Role in Lung Homeostasis.肺表面活性剂系统中的脂质-蛋白和蛋白-蛋白相互作用及其在肺稳态中的作用。
Int J Mol Sci. 2020 May 25;21(10):3708. doi: 10.3390/ijms21103708.
6
Alveolar Dynamics and Beyond - The Importance of Surfactant Protein C and Cholesterol in Lung Homeostasis and Fibrosis.肺泡动力学及其他——表面活性蛋白C和胆固醇在肺稳态及纤维化中的重要性
Front Physiol. 2020 May 5;11:386. doi: 10.3389/fphys.2020.00386. eCollection 2020.
7
Divide & Conquer: Surfactant Protein SP-C and Cholesterol Modulate Phase Segregation in Lung Surfactant.分而治之:表面活性蛋白SP-C与胆固醇调节肺表面活性剂中的相分离
Biophys J. 2017 Aug 22;113(4):847-859. doi: 10.1016/j.bpj.2017.06.059.
8
Effect of Lung Surfactant Protein SP-C and SP-C-Promoted Membrane Fragmentation on Cholesterol Dynamics.肺表面活性蛋白SP-C及SP-C促进的膜碎片化对胆固醇动力学的影响
Biophys J. 2016 Oct 18;111(8):1703-1713. doi: 10.1016/j.bpj.2016.09.016.
9
Surfactant protein C peptides with salt-bridges ("ion-locks") promote high surfactant activities by mimicking the α-helix and membrane topography of the native protein.具有盐桥(“离子锁”)的表面活性蛋白 C 肽通过模拟天然蛋白的α-螺旋和膜拓扑结构来提高表面活性剂的活性。
PeerJ. 2014 Jul 15;2:e485. doi: 10.7717/peerj.485. eCollection 2014.
10
The lung alveolar lipofibroblast: an evolutionary strategy against neonatal hyperoxic lung injury.肺泡脂肪成纤维细胞:一种对抗新生儿高氧性肺损伤的进化策略。
Antioxid Redox Signal. 2014 Nov 1;21(13):1893-904. doi: 10.1089/ars.2013.5793. Epub 2014 Mar 12.

本文引用的文献

1
Pulmonary surfactant protein SP-C counteracts the deleterious effects of cholesterol on the activity of surfactant films under physiologically relevant compression-expansion dynamics.肺表面活性物质蛋白 SP-C 可对抗胆固醇在生理相关压缩-扩张动力学下对表面活性剂膜活性的有害影响。
Biophys J. 2009 Nov 18;97(10):2736-45. doi: 10.1016/j.bpj.2009.08.045.
2
Segregated phases in pulmonary surfactant membranes do not show coexistence of lipid populations with differentiated dynamic properties.肺表面活性物质膜中的分离相并未显示出具有不同动态特性的脂质群体共存。
Biophys J. 2009 Sep 2;97(5):1381-9. doi: 10.1016/j.bpj.2009.06.040.
3
Cholesterol modulates the exposure and orientation of pulmonary surfactant protein SP-C in model surfactant membranes.胆固醇调节模型表面活性剂膜中肺表面活性蛋白SP-C的暴露和取向。
Biochim Biophys Acta. 2009 Sep;1788(9):1907-15. doi: 10.1016/j.bbamem.2009.05.011. Epub 2009 May 22.
4
Structure of pulmonary surfactant membranes and films: the role of proteins and lipid-protein interactions.肺表面活性物质膜和薄膜的结构:蛋白质及脂蛋白相互作用的作用
Biochim Biophys Acta. 2008 Jul-Aug;1778(7-8):1676-95. doi: 10.1016/j.bbamem.2008.05.003. Epub 2008 May 11.
5
Current perspectives in pulmonary surfactant--inhibition, enhancement and evaluation.肺表面活性物质的当前观点——抑制、增强与评估
Biochim Biophys Acta. 2008 Oct;1778(10):1947-77. doi: 10.1016/j.bbamem.2008.03.021. Epub 2008 Apr 8.
6
Surfactant proteins B and C are both necessary for alveolar stability at end expiration in premature rabbits with respiratory distress syndrome.表面活性蛋白B和C对于患有呼吸窘迫综合征的早产兔呼气末期的肺泡稳定性均是必需的。
J Appl Physiol (1985). 2008 Apr;104(4):1101-8. doi: 10.1152/japplphysiol.00865.2007. Epub 2008 Feb 14.
7
Biochemical and pharmacological differences between preparations of exogenous natural surfactant used to treat Respiratory Distress Syndrome: role of the different components in an efficient pulmonary surfactant.用于治疗呼吸窘迫综合征的外源性天然表面活性剂制剂之间的生化和药理学差异:不同成分在有效肺表面活性剂中的作用
Eur J Pharmacol. 2007 Jul 30;568(1-3):1-15. doi: 10.1016/j.ejphar.2007.04.035. Epub 2007 Apr 30.
8
An elevated level of cholesterol impairs self-assembly of pulmonary surfactant into a functional film.胆固醇水平升高会损害肺表面活性物质自组装成功能性薄膜的过程。
Biophys J. 2007 Jul 15;93(2):674-83. doi: 10.1529/biophysj.107.106310. Epub 2007 May 4.
9
Patients with ARDS show improvement but not normalisation of alveolar surface activity with surfactant treatment: putative role of neutral lipids.急性呼吸窘迫综合征患者经表面活性剂治疗后肺泡表面活性有所改善,但未恢复正常:中性脂质的假定作用
Thorax. 2007 Jul;62(7):588-94. doi: 10.1136/thx.2006.062398. Epub 2007 Feb 7.
10
The evolution of a physiological system: the pulmonary surfactant system in diving mammals.生理系统的演化:潜水哺乳动物的肺表面活性物质系统
Respir Physiol Neurobiol. 2006 Nov;154(1-2):118-38. doi: 10.1016/j.resp.2006.04.012. Epub 2006 Apr 28.

棕榈酰化肺表面活性蛋白 SP-C 对于其与 SP-B 的功能合作至关重要,以维持含有胆固醇的表面活性剂膜的压缩/扩张动力学。

Palmitoylation of pulmonary surfactant protein SP-C is critical for its functional cooperation with SP-B to sustain compression/expansion dynamics in cholesterol-containing surfactant films.

机构信息

Departamento de Bioquímica, Universidad Complutense, Madrid, Spain.

出版信息

Biophys J. 2010 Nov 17;99(10):3234-43. doi: 10.1016/j.bpj.2010.08.070.

DOI:10.1016/j.bpj.2010.08.070
PMID:21081071
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2980709/
Abstract

Recent data suggest that a functional cooperation between surfactant proteins SP-B and SP-C may be required to sustain a proper compression-expansion dynamics in the presence of physiological proportions of cholesterol. SP-C is a dually palmitoylated polypeptide of 4.2 kDa, but the role of acylation in SP-C activity is not completely understood. In this work we have compared the behavior of native palmitoylated SP-C and recombinant nonpalmitoylated versions of SP-C produced in bacteria to get a detailed insight into the importance of the palmitic chains to optimize interfacial performance of cholesterol-containing surfactant films. We found that palmitoylation of SP-C is not essential for the protein to promote rapid interfacial adsorption of phospholipids to equilibrium surface tensions (∼22 mN/m), in the presence or absence of cholesterol. However, palmitoylation of SP-C is critical for cholesterol-containing films to reach surface tensions ≤1 mN/m at the highest compression rates assessed in a captive bubble surfactometer, in the presence of SP-B. Interestingly, the ability of SP-C to facilitate reinsertion of phospholipids during expansion was not impaired to the same extent in the absence of palmitoylation, suggesting the existence of palmitoylation-dependent and -independent functions of the protein. We conclude that palmitoylation is key for the functional cooperation of SP-C with SP-B that enables cholesterol-containing surfactant films to reach very low tensions under compression, which could be particularly important in the design of clinical surfactants destined to replacement therapies in pathologies such as acute respiratory distress syndrome.

摘要

最近的数据表明,在存在生理比例胆固醇的情况下,表面活性蛋白 SP-B 和 SP-C 之间的功能合作可能是维持适当的压缩-扩张动力学所必需的。SP-C 是一种具有双重棕榈酰化的 4.2 kDa 多肽,但酰化作用在 SP-C 活性中的作用尚未完全阐明。在这项工作中,我们比较了天然棕榈酰化 SP-C 和在细菌中产生的重组非棕榈酰化 SP-C 的行为,以深入了解棕榈酸链对优化含胆固醇表面活性剂膜的界面性能的重要性。我们发现,棕榈酰化 SP-C 对于促进磷脂在存在或不存在胆固醇的情况下快速吸附到平衡表面张力(约 22 mN/m)是不必要的。然而,在存在 SP-B 的情况下,对于含胆固醇的膜,棕榈酰化 SP-C 对于达到最高压缩速率评估的表面张力≤1 mN/m 是至关重要的。有趣的是,在没有棕榈酰化的情况下,SP-C 促进磷脂在扩张过程中重新插入的能力并没有受到同样程度的损害,这表明该蛋白存在棕榈酰化依赖和非依赖的功能。我们得出结论,棕榈酰化对于 SP-C 与 SP-B 的功能合作至关重要,这使得含胆固醇的表面活性剂膜能够在压缩下达到非常低的张力,这在设计用于治疗急性呼吸窘迫综合征等病理的临床表面活性剂替代疗法时可能特别重要。